Publication Cover
Stress
The International Journal on the Biology of Stress
Volume 15, 2012 - Issue 6
1,047
Views
42
CrossRef citations to date
0
Altmetric
Original Research Reports

Circadian activity of the hypothalamic–pituitary–adrenal axis is differentially affected in the rat chronic mild stress model of depression

, , &
Pages 647-657 | Received 23 Jun 2011, Accepted 28 Nov 2011, Published online: 23 Feb 2012

References

  • Antonijevic I. 2008. HPA axis and sleep: Identifying subtypes of major depression. Stress. 11:15–27.
  • Antonijevic IA, Murck H, Frieboes RM, Steiger A. 2000. Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls—part II: Hormone secretion. Sleep Res Online.. 3:15–21.
  • Banki CM, Arato M, Papp Z, Rihmer Z, Kovacs Z. 1986. Associations among dexamethasone non-suppression and TRH-induced hormonal responses: Increased specificity for melancholia?. Psychoneuroendocrinology. 11:205–211.
  • Barone FC, Deegan JF, Price WJ, Fowler PJ, Fondacaro JD, Ormsbee HSIII. 1990. Cold-restraint stress increases rat fecal pellet output and colonic transit. Am J Physiol. 258:G329–G337.
  • Barrett EJ. 2009. Organization of endocrine control. In: Boron WF, Boulpaep EL. editors. Medical physiology. Philadelphia, PA: Saunders/Elsevier1003–1017.
  • Calfa G, Kademian S, Ceschin D, Vega G, Rabinovich GA, Volosin M. 2003. Characterization and functional significance of glucocorticoid receptors in patients with major depression: Modulation by antidepressant treatment. Psychoneuroendocrinology. 28:687–701.
  • Caroff S, Winokur A, Rieger W, Schweizer E, Amsterdam J. 1983. Response to dexamethasone in psychotic depression. Psychiatry Res.. 8:59–64.
  • Carroll BJ. 1982. Clinical applications of the dexamethasone suppression test for endogenous depression. Pharmacopsychiatria.. 15:19–25.
  • Checkley S. 1996. The neuroendocrinology of depression and chronic stress. Br Med Bull. 52:597–617.
  • De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. 1998. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 19:269–301.
  • Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, Standhardt H, Lammers CH, Heuser I. 1997. Diurnal activity and pulsatility of the hypothalamus–pituitary–adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab. 82:234–238.
  • Dinan TG. 1994. Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br J Psychiatry. 164:365–371.
  • Gold PW, Licinio J, Wong ML, Chrousos GP. 1995. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann NY Acad Sci. 771:716–729.
  • Grippo AJ, Francis J, Beltz TG, Felder RB, Johnson AK. 2005. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav. 84:697–706.
  • Gronli J, Murison R, Bjorvatn B, Sorensen E, Portas CM, Ursin R. 2004. Chronic mild stress affects sucrose intake and sleep in rats. Behav Brain Res. 150:139–147.
  • Henningsen K, Andreasen JT, Bouzinova EV, Jayatissa MN, Jensen MS, Redrobe JP, Wiborg O. 2009. Cognitive deficits in the rat chronic mild stress model for depression: Relation to anhedonic-like responses. Behav Brain Res. 198:136–141.
  • Jarque CM, Bera AK. 1980. Efficient tests for normality, homoscedasticity and serial independence of regression residuals. Econ Lett. 6:255–259.
  • Jayatissa MN, Bisgaard C, Tingstrom A, Papp M, Wiborg O. 2006. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology. 31:2395–2404.
  • Kathol RG, Jaeckle RS, Lopez JF, Meller WH. 1989. Pathophysiology of HPA axis abnormalities in patients with major depression: An update. Am J Psychiatry. 146:311–317.
  • Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R, Siever LJ. 2004. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res. 38:503–511.
  • Lepschy M, Touma C, Palme R. 2010. Faecal glucocorticoid metabolites: How to express yourself—comparison of absolute amounts versus concentrations in samples from a study in laboratory rats. Lab Anim. 44:192–198.
  • Lepschy M, Touma C, Hruby R, Palme R. 2007. Non-invasive measurement of adrenocortical activity in male and female rats. Lab Anim. 41:372–387.
  • Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, Copinschi G, Van CE. 1987. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: Effect of antidepressant treatment. J Clin Endocrinol Metab. 65:141–152.
  • Maes M. 1999. Major depression and activation of the inflammatory response system. Adv Exp Med Biol. 461:25–46.
  • Nemenyi PB. 1963. Distribution-free multiple comparisons. Princeton University: Doctoral thesis.
  • Nemeroff CB, Vale WW. 2005. The neurobiology of depression: Inroads to treatment and new drug discovery. J Clin Psychiatry. 66:5–13.
  • Palacios R, Campo A, Henningsen K, Verhoye M, Poot D, Dijkstra J, Van AJ, Benveniste H, Sijbers J, Wiborg O, Van der LA. 2011. Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol Psychiatry. 70:449–457.
  • Pariante CM. 2006. The glucocorticoid receptor: Part of the solution or part of the problem?. J Psychopharmacol. 20:79–84.
  • Pariante CM, Miller AH. 2001. Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biol Psychiatry. 49:391–404.
  • Pittenger C, Duman RS. 2008. Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology.. 33:88–109.
  • Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL. 1987. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry. 44:328–336.
  • Shapiro SS, Wilk MB. 1965. An analysis of variance test for normality (complete samples). Biometrika. 52:591–611.
  • Stetler C, Miller GE. 2011. Depression and hypothalamic–pituitary–adrenal activation: A quantitative summary of four decades of research. Psychosom Med. 73:114–126.
  • Streeten DH, Anderson GHJr, Dalakos TG, Seeley D, Mallov JS, Eusebio R, Sunderlin FS, Badawy SZ, King RB. 1984. Normal and abnormal function of the hypothalamic–pituitary–adrenocortical system in man. Endocr Rev. 5:371–394.
  • Surget A, Tanti A, Leonardo ED, Laugeray A, Rainer Q, Touma C, Palme R, Griebel G, Ibarguen-Vargas Y, Hen R, Belzung C. 2011. Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry. 16:1177–1188.
  • Touma C, Bunck M, Glasl L, Nussbaumer M, Palme R, Stein H, Wolferstatter M, Zeh R, Zimbelmann M, Holsboer F, Landgraf R. 2008. Mice selected for high versus low stress reactivity: A new animal model for affective disorders. Psychoneuroendocrinology. 33:839–862.
  • Touma C, Fenzl T, Ruschel J, Palme R, Holsboer F, Kimura M, Landgraf R. 2009. Rhythmicity in mice selected for extremes in stress reactivity: Behavioural, endocrine and sleep changes resembling endophenotypes of major depression. PLoS. One.. 4:e4325.
  • Touma C, Palme R, Sachser N. 2004. Analyzing corticosterone metabolites in fecal samples of mice: A noninvasive technique to monitor stress hormones. Horm Behav. 45:10–22.
  • Touma C, Sachser N, Mostl E, Palme R. 2003. Effects of sex and time of day on metabolism and excretion of corticosterone in urine and feces of mice. Gen Comp Endocrinol. 130:267–278.
  • Willner P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology (Berl). 134:319–329.
  • Willner P. 2005. Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology.. 52:90–110.
  • Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD, Jr., DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW. 2000. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA. 97:325–330.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.